Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7210-7232
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7210
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7210
Current phase | Title | ClinicalTrials.gov Identifier | First posted |
NA | Fecal microbiota transplantation for C. difficile infection | NCT01905709 | July 23, 2013 |
Immune response to FMT for C. difficile | NCT02797288 | June 13, 2016 | |
Outcomes and data collection for fecal microbiota transplantation for the treatment of recurrent C. difficile | NCT03562741 | June 19, 2018 | |
Fecal microbiota transplantation (FMT) for C. difficile (CEFTA) | NCT03712722 | October 1, 2018 | |
Rescue fecal microbiota transplantation for national refractory intestinal infection | NCT03895593 | March 29, 2019 | |
Safety and efficacy of fecal microbiota transplantation | NCT04014413 | July 10, 2019 | |
1 | Fecal transplant for pediatric patients who have recurrent C. difficile infection (FMT) | NCT02134392 | May 9, 2014 |
2 | Stool transplants to treat refractory C. difficile | NCT02127398 | April 30, 2014 |
FMT versus antimicrobials for initial treatment of recurrent CDI | NCT02255305 | October 2, 2014 | |
Fecal microbiota therapy for recurrent C. difficile infection | NCT02686645 | February 19, 2016 | |
Phase II trial of fecal microbiota transplant (FMT) for VRE and CRE patients | NCT03643887 | August 23, 2018 | |
Fecal microbiota transplantation (FMT) plus fidaxomicin for severe of fulminant C. difficile | NCT03760484 | November 30, 2018 | |
Multicentre blinded comparison of lyophilized sterile fecal filtrate to lyophilized fecal microbiota transplant in recurrent C. difficile infection | NCT03806803 | January 16, 2019 | |
FMT and bezltoxumab compared to FMT and placebo for patients with IBD and CDI (ICON-2) | NCT03829475 | February 4, 2019 | |
PMT for severe-CDI | NCT03970200 | May 31, 2019 | |
Penn microbiome therapy (PMT) for recurrent C. difficile infection | NCT03973697 | June 4, 2019 | |
3 | Fecal transplantation for primary C. difficile infection (COLONIZE) | NCT03796650 | January 8, 2019 |
Microbiota restoration therapy for recurrent C. difficile infection (PUNCH CD3-OLS) (CD3-OLS) | NCT03931941 | April 30, 2019 | |
Fecal microbiota transplantation for primary C. difficile diarrhea | NCT02801656 | June 16, 2016 |
- Citation: Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7210